UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060608
Receipt number R000069318
Scientific Title Research on the Pathophysiology of Psychiatric and Neurological Disorders Using EEG
Date of disclosure of the study information 2026/02/06
Last modified on 2026/02/06 18:47:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the Pathophysiology of Psychiatric and Neurological Disorders Using EEG

Acronym

Research on the Pathophysiology of Psychiatric and Neurological Disorders Using EEG

Scientific Title

Research on the Pathophysiology of Psychiatric and Neurological Disorders Using EEG

Scientific Title:Acronym

Research on the Pathophysiology of Psychiatric and Neurological Disorders Using EEG

Region

Japan


Condition

Condition

neuropsychiatric disorder

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether electroencephalogram (EEG) testing can be useful for the diagnosis and treatment of mental and neurological disorders.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between EEG biomarkers and patients with psychiatric and neurological disorders

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

EEG measurement

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals who have received sufficient explanation regarding study participation and have provided written consent

Key exclusion criteria

Individuals with hearing impairments

Target sample size

1200


Research contact person

Name of lead principal investigator

1st name Mariko
Middle name
Last name Tada

Organization

Juntendo University

Division name

Department of Psychiatry and Behavioral Science

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-Ku, Tokyo,

TEL

03-3813-3111

Email

mariko.tada@juntendo.ac.jp


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Tada

Organization

Juntendo University

Division name

Department of Psychiatry and Behavioral Science

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-Ku, Tokyo,

TEL

03-3813-3111

Homepage URL


Email

mariko.tada@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

JST

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Hospital Clinical Research and Trial Center

Address

3-1-3,Hongo,Bunkyo-ku,Tokyo

Tel

03-5802-1584

Email

jcrtc_operation@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 06 Day

Date of IRB


Anticipated trial start date

2026 Year 03 Month 01 Day

Last follow-up date

2031 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 06 Day

Last modified on

2026 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069318